Specific Characteristics of Praluent – Praluent (alirocumab)

Pharmacological properties

Pharmacological properties

Figure © Sanofi.

Data based on PK/PD studies may not always correlate with clinical efficacy

PRALUENT ADMINISTRATION

PRALUENT^® MECHANISM OF ACTION

References

Praluent^® (alirocumab) European Summary of Product Characteristics. March 2019.
Kuhnast S, et al. J Lipid Res 2014;55:2103–2112.